Previous 10 | Next 10 |
2023-10-24 14:38:06 ET Summary ImmunityBio, Inc.'s drug Anktiva received a Complete Response Letter, or CRL, from the FDA, delaying its approval for the treatment of NMIBC. The CRL was related to deficiencies in the FDA's inspection of the company's third-party contract manufactur...
2023-10-24 12:25:10 ET More on ImmunityBio ImmunityBio: Ongoing Dilution And Regulatory Uncertainties Blur Investment Prospects ImmunityBio announces $470M equity and debt financing from founder Patrick Soon-Shiong and Nant Entities Seeking Alpha’s Quant Ratin...
2023-10-24 10:01:59 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in For further details see: American Well Corporation, ImmunityBio amon...
2023-10-23 10:00:15 ET Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: ImmunityBio, Palatin Technologies among healthcare movers
Provides updated data on prolonged duration of complete response in BCG-Unresponsive and BCG-Naïve NMIBC patients Following the Type A Meeting with the FDA, ImmunityBio has completed the BLA resubmission addressing the issues in the Complete Response Letter. As part of this resub...
SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of ImmunityBio, Inc. (NASDAQ: IBRX). Investors, who purchased ImmunityBio, Inc. (NASDAQ: IBRX) shares prior to May 2022 and continue to hold any o...
2023-09-27 08:30:53 ET MillerKnoll ( MLKN ) +17% rides 18% higher, sees improving organic orders during FQ1. Gaucho Group Holdings ( VINO ) +15% . Ginkgo Bioworks Holdings ( DNA ) +16% Announces Multi-Target RNA Discovery Collaboration w...
2023-09-15 15:27:31 ET The Allure of Short Squeeze Penny Stocks: High Risk, High Reward Trading Penny stocks, typically defined as stocks trading under $5 per share, offer traders massive upside profit potential but also higher risk due to greater volatility. When penny stocks becom...
2023-09-15 12:52:24 ET Shares of ImmunityBio (NASDAQ: IBRX) were up more than 30% for the week as of 10 a.m. ET on Friday, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech 's stock closed at $1.29 last week and then rose to as hig...
2023-09-11 06:26:56 ET ImmunityBio ( NASDAQ: IBRX ) Monday said it has executed financing transactions resulting in about $200 million of proceeds to the company. The transaction includes an exchange into equity of current debt and a new convertible debt instrument from Nant C...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 01:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ImmunityBio, Inc. (NasdaqGS: IBRX). On May 11, 2023, the Company disclosed that it had receiv...